An 84-year-old man left clinicians at a Hong Kong hospital utterly perplexed after arriving at the hospital to be treated […] ...

Managing the unpredictable symptoms of indolent systemic mastocytosis prompted a search for answers and community.

Epidermolysis Bullosa (EB), or butterfly disease, affects 1 in 50,000 people, causing fragile skin that blisters easily, ...

Jeremiah Marshall has lived with epidermolysis bullosa since the day he was born and has had to endure teasing at school, ...

Argyria is caused by a buildup of silver in the body, which discolors the skin.

Researchers find that allergy medicine could help patients with a rare genetic disease avoid liver transplants.

Mayo Clinic's organoids, microscopic versions of organs that function like the real ones, have been used by doctors to study ...

Quoin Pharmaceuticals, a biotech company with a keen focus on rare diseases, has recently been making waves in the world of dermatology with its treatment for Netherton Syndrome. This rare genetic ...

Skinvisible granted Quoin an exclusive, royalty-bearing license to its technology for use in select rare skin diseases and for the right to use its proprietary formula for Netherton Syndrome.

Jeremiah Marshall, 33, has epidermolysis bullosa, a rare genetic disorder that makes his skin tear or blister at the ...

Sanofi and Regeneron's Dupixent has become the first biologic drug to show activity in prurigo nodularis (PN), raising the hope of a new treatment option for the rare and highly debilitating skin ...

Skinvisible granted Quoin an exclusive, royalty-bearing license to its technology for use in select rare skin diseases and for the right to use its proprietary formula for Netherton Syndrome.